Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Velaglucerase_alfa> ?p ?o }
Showing triples 1 to 81 of
81
with 100 triples per page.
- Velaglucerase_alfa abstract "Velaglucerase alfa (trade name VPRIV), manufactured by Shire plc is a hydrolytic lysosomal glucocerebroside-specific enzyme, which is a recombinant form of glucocerebrosidase indicated as a long-term enzyme replacement therapy for those suffering of Gaucher disease Type 1. It has an identical amino acid sequence to the naturally occurring enzyme. It was approved for use by the U.S. Food and Drug Administration (FDA) on February 26, 2010.".
- Velaglucerase_alfa atcPrefix "A16".
- Velaglucerase_alfa atcSuffix "AB10".
- Velaglucerase_alfa fdaUniiCode "23HYE36B0I".
- Velaglucerase_alfa wikiPageID "26441610".
- Velaglucerase_alfa wikiPageLength "2840".
- Velaglucerase_alfa wikiPageOutDegree "17".
- Velaglucerase_alfa wikiPageRevisionID "545865825".
- Velaglucerase_alfa wikiPageWikiLink Atomic_mass_unit.
- Velaglucerase_alfa wikiPageWikiLink Blood_plasma.
- Velaglucerase_alfa wikiPageWikiLink Category:Orphan_drugs.
- Velaglucerase_alfa wikiPageWikiLink Category:Recombinant_proteins.
- Velaglucerase_alfa wikiPageWikiLink Food_and_Drug_Administration.
- Velaglucerase_alfa wikiPageWikiLink Gaucher_disease.
- Velaglucerase_alfa wikiPageWikiLink Gauchers_disease.
- Velaglucerase_alfa wikiPageWikiLink Genzyme.
- Velaglucerase_alfa wikiPageWikiLink Glucocerebrosidase.
- Velaglucerase_alfa wikiPageWikiLink Glucocerebroside.
- Velaglucerase_alfa wikiPageWikiLink Glycosylate.
- Velaglucerase_alfa wikiPageWikiLink Glycosylation.
- Velaglucerase_alfa wikiPageWikiLink Imiglucerase.
- Velaglucerase_alfa wikiPageWikiLink KDa.
- Velaglucerase_alfa wikiPageWikiLink Lysosomal.
- Velaglucerase_alfa wikiPageWikiLink Lysosome.
- Velaglucerase_alfa wikiPageWikiLink Macrophage.
- Velaglucerase_alfa wikiPageWikiLink Pfizer.
- Velaglucerase_alfa wikiPageWikiLink Protalix.
- Velaglucerase_alfa wikiPageWikiLink Protalix_BioTherapeutics.
- Velaglucerase_alfa wikiPageWikiLink Shire_(pharmaceutical_company).
- Velaglucerase_alfa wikiPageWikiLink Shire_plc.
- Velaglucerase_alfa wikiPageWikiLink Taliglucerase_alfa.
- Velaglucerase_alfa wikiPageWikiLink Taliglucerase_alpha.
- Velaglucerase_alfa wikiPageWikiLink U.S._Food_and_Drug_Administration.
- Velaglucerase_alfa wikiPageWikiLinkText "Velaglucerase alfa".
- Velaglucerase_alfa wikiPageWikiLinkText "velaglucerase alfa".
- Velaglucerase_alfa atcPrefix "A16".
- Velaglucerase_alfa atcSuffix "AB10".
- Velaglucerase_alfa bioavailability "N/A".
- Velaglucerase_alfa c "2532".
- Velaglucerase_alfa chembl "1201865".
- Velaglucerase_alfa chemspiderid "NA".
- Velaglucerase_alfa eliminationHalfLife "-720.0".
- Velaglucerase_alfa h "3850".
- Velaglucerase_alfa hasPhotoCollection Velaglucerase_alfa.
- Velaglucerase_alfa legalStatus "Rx".
- Velaglucerase_alfa molecularWeight "55.5".
- Velaglucerase_alfa n "672".
- Velaglucerase_alfa o "711".
- Velaglucerase_alfa routesOfAdministration "Infusion".
- Velaglucerase_alfa s "16".
- Velaglucerase_alfa unii "23".
- Velaglucerase_alfa verifiedfields "changed".
- Velaglucerase_alfa verifiedrevid "470629507".
- Velaglucerase_alfa wikiPageUsesTemplate Template:Drugbox.
- Velaglucerase_alfa wikiPageUsesTemplate Template:Gastrointestinal-drug-stub.
- Velaglucerase_alfa wikiPageUsesTemplate Template:Other_alimentary_tract_and_metabolism_products.
- Velaglucerase_alfa wikiPageUsesTemplate Template:Reflist.
- Velaglucerase_alfa subject Category:Orphan_drugs.
- Velaglucerase_alfa subject Category:Recombinant_proteins.
- Velaglucerase_alfa hypernym Enzyme.
- Velaglucerase_alfa type Article.
- Velaglucerase_alfa type ChemicalSubstance.
- Velaglucerase_alfa type Drug.
- Velaglucerase_alfa type Protein.
- Velaglucerase_alfa type Article.
- Velaglucerase_alfa type Chemical.
- Velaglucerase_alfa type Drug.
- Velaglucerase_alfa type Product.
- Velaglucerase_alfa type ChemicalObject.
- Velaglucerase_alfa type Thing.
- Velaglucerase_alfa type Q8386.
- Velaglucerase_alfa comment "Velaglucerase alfa (trade name VPRIV), manufactured by Shire plc is a hydrolytic lysosomal glucocerebroside-specific enzyme, which is a recombinant form of glucocerebrosidase indicated as a long-term enzyme replacement therapy for those suffering of Gaucher disease Type 1. It has an identical amino acid sequence to the naturally occurring enzyme. It was approved for use by the U.S. Food and Drug Administration (FDA) on February 26, 2010.".
- Velaglucerase_alfa label "Velaglucerase alfa".
- Velaglucerase_alfa sameAs Velaglucerase_alfa.
- Velaglucerase_alfa sameAs m.0bbwfy6.
- Velaglucerase_alfa sameAs Velagluceraza_alfa.
- Velaglucerase_alfa sameAs Velagluceraza_alfa.
- Velaglucerase_alfa sameAs Q3492447.
- Velaglucerase_alfa sameAs Q3492447.
- Velaglucerase_alfa wasDerivedFrom Velaglucerase_alfa?oldid=545865825.
- Velaglucerase_alfa isPrimaryTopicOf Velaglucerase_alfa.